Vaxart Inc. (United States) is listed on the Nasdaq and has a market capitalization of $134.95 million, with shareholders equity totaling $94.12 million.
The company employs approximately 49 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Vaxart Inc. reported $255.61 million in revenue, generating net income of $37.10 million.
Key financial metrics include a P/E ratio of 3.64, a price-to-book (P/B) ratio of 1.43, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker VXRT.